Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cancer Research

• Publication date

  2008-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-08-1510PMID 18794155PMCID PMC2562581
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PINCH-1 Regulates the ERK-Bim Pathway and Contributes to Apoptosis Resistance in Cancer Cells*

  2008influential reference
• Honokiol, a Constituent of Oriental Medicinal Herb Magnolia officinalis, Inhibits Growth of PC-3 Xenografts In vivo in Association with Apoptosis Induction

  2008cited by this paper
• The Tumor Proteasome Is a Primary Target for the Natural Anticancer Compound Withaferin A Isolated from “Indian Winter Cherry”

  2007cited by this paper
• Guggulsterone-induced apoptosis in human prostate cancer cells is caused by reactive oxygen intermediate dependent activation of c-Jun NH2-terminal kinase.

  2007cited by this paper
• Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells.

  2007cited by this paper
• Withaferin A Strongly Elicits IκB Kinase β Hyperphosphorylation Concomitant with Potent Inhibition of Its Kinase Activity*

  2007cited by this paper
• Withania somnifera inhibits NF‐κB and AP‐1 transcription factors in human peripheral blood and synovial fluid mononuclear cells

  2007cited by this paper
• Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine

  2007cited by this paper
• Cancer Statistics, 2006

  2006cited by this paper
• Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-κB (NF-κB) activation and NF-κB–regulated gene expression

  2006cited by this paper
• The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions

  2006cited by this paper
• Diallyl Trisulfide Suppresses Growth of PC-3 Human Prostate Cancer Xenograft In vivo in Association with Bax and Bak Induction

  2006cited by this paper
• Immunomodulatory role of Withania somnifera root powder on experimental induced inflammation: An in vivo and in vitro study.

  2006cited by this paper
• Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-kappaB (NF-kappaB) activation and NF-kappaB-regulated gene expression.

  2006cited by this paper
• Benzyl isothiocyanate–induced apoptosis in human breast cancer cells is initiated by reactive oxygen species and regulated by Bax and Bak

  2006cited by this paper
• Actin microfilament aggregation induced by withaferin A is mediated by annexin II

  2006cited by this paper
• Antibacterial efficacy of Withania somnifera (ashwagandha) an indigenous medicinal plant against experimental murine salmonellosis.

  2005cited by this paper
• Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells

  2005influential reference
• Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats

  2005cited by this paper
• Bax and Bak are required for apoptosis induction by sulforaphane, a cruciferous vegetable-derived cancer chemopreventive agent.

  2005cited by this paper
• Epidemiology and Prevention of Breast Cancer

  2005cited by this paper
• Withaferin A is a potent inhibitor of angiogenesis

  2004cited by this paper
• Cardioprotection from ischemia and reperfusion injury by Withania somnifera: A hemodynamic, biochemical and histopathological assessment

  2004cited by this paper
• Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2

  2004cited by this paper
• Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo.

  2003cited by this paper
• JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis.

  2003cited by this paper
• Natural products as sources of new drugs over the period 1981-2002.

  2003cited by this paper
• Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis.

  2003cited by this paper
• First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial.

  2002cited by this paper
• Induction of BIM, a proapoptotic BH3-only BCL-2 family member, is critical for neuronal apoptosis.

  2001cited by this paper
• BH3-only Bcl-2 family members are coordinately regulated by the JNK pathway and require Bax to induce apoptosis in neurons.

  2001cited by this paper
• Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release.

  2001cited by this paper
• Radiosensitization of a mouse melanoma by withaferin A: in vivo studies.

  2000cited by this paper
• Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1.

  2000cited by this paper
• Role of p53 family members in apoptosis

  2000cited by this paper
• The proapoptotic BH3-only protein bim is expressed in hematopoietic, epithelial, neuronal, and germ cells.

  2000cited by this paper
• Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review.

  2000cited by this paper
• Studies on immunomodulatory activity of Withania somnifera (Ashwagandha) extracts in experimental immune inflammation.

  1999cited by this paper
• Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

  1999cited by this paper
• The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex.

  1999influential reference
• The Bcl-2 protein family: arbiters of cell survival.

  1998cited by this paper
• BCL-2 family: regulators of cell death.

  1998cited by this paper
• Epidemiology and prevention of breast cancer.

  1996cited by this paper
• Withaferin A: a new radiosensitizer from the Indian medicinal plant Withania somnifera.

  1996cited by this paper
• Breast cancer: cause and prevention

  1995cited by this paper
• In vivo growth inhibitory and radiosensitizing effects of withaferin A on mouse Ehrlich ascites carcinoma.

  1995cited by this paper
• Reproductive factors and breast cancer.

  1993cited by this paper
• In vivo growth inhibitory effect of Withania somnifera (Ashwagandha) on a transplantable mouse tumor, Sarcoma 180.

  1992cited by this paper
• Scientific Basis for the Therapeutic Use of Withania somnifera (Ashwagandha): A Review

  year unknowncited by this paper

• Exploring the therapeutic potential of withaferin A by modulating key oncosignaling pathways.

  2026cites this paper
• Ashwagandha (Withania Somnifera): a comprehensive narrative review of its role in enhancing physical performance and health.

  2026cites this paper
• Unraveling the role of withanolides as key modulators in breast cancer mitigation

  2025cites this paper
• Interpretable prediction of drug synergy for breast cancer by random forest with features from Boolean modeling of signaling pathways

  2025cites this paper
• "Integrative Oncology: Uniting Herbal and Allopathic Medicine for Cancer Management"

  2025cites this paper
• Implications of Mineralization Biomarkers in Breast Cancer Outcomes Beyond Calcifications

  2025cites this paper
• Mechanisms and potential therapeutic strategies of withaferin A in breast cancer

  2025cites this paper
• Transcriptome analysis reveals a role of FOXO3 in antileukemia/lymphoma properties of panduratin A

  2024cites this paper
• Molecular insights into withaferin A: A holistic approach to cancer therapy

  2024cites this paper
• Ashwagandha-Induced Programmed Cell Death in the Treatment of Breast Cancer

  2024cites this paper
• An update on existing therapeutic options and status of novel anti-metastatic agents in breast cancer: Elucidating the molecular mechanisms underlying the pleiotropic action of Withania somnifera (Indian ginseng) in breast cancer attenuation.

  2024cites this paper
• Unlocking the epigenetic code: new insights into triple-negative breast cancer

  2024cites this paper
• Withanolides: Promising candidates for cancer therapy

  2024cites this paper
• Role and regulation of FOXO3a: new insights into breast cancer therapy

  2024influential citation
• Withanolide derivatives: natural compounds with anticancer potential offer low toxicity to fertility and ovarian follicles in mice

  2024cites this paper
• Therapeutic and pharmacological efficacy of plant-derived bioactive compounds in targeting breast cancer.

  2024cites this paper
• Phyto-therapeutics as anti-cancer agents in breast cancer: Pathway targeting and mechanistic elucidation

  2024cites this paper
• Nanoscale insight into biochemical changes in cervical cancer cells exposed to adaptogenic drug.

  2023cites this paper
• Disruption of Proteostasis by Natural Products and Synthetic Compounds That Induce Pervasive Unfolding of Proteins: Therapeutic Implications

  2023cites this paper
• Withaferin A, a natural thioredoxin reductase 1 (TrxR1) inhibitor, synergistically enhances the antitumor efficacy of sorafenib through ROS-mediated ER stress and DNA damage in hepatocellular carcinoma cells.

  2023cites this paper
• The use of African medicinal plants in cancer management

  2023cites this paper
• The Therapeutic Effects of Withaferin A against Cancer: Overview and Updates.

  2023cites this paper
• Biodiversity, Biochemical Profiling, and Pharmaco-Commercial Applications of Withania somnifera: A Review

  2023cites this paper
• Withaferin A: A Pleiotropic Anticancer Agent from the Indian Medicinal Plant Withania somnifera (L.) Dunal

  2023cites this paper
• Tubulin degradation: Principles, agents, and applications.

  2023cites this paper
• Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for Cancer Treatment - Pharmacology and Mechanisms

  2023cites this paper
• Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds

  2023cites this paper
• Withaferin A inhibits breast cancer‐induced osteoclast differentiation

  2023cites this paper
• MiR-182 promotes apoptosis of neural cells in cerebral infarction rats by PI3K/AKT signaling pathway.

  2023cites this paper
• HIV Infection: Shaping the Complex, Dynamic, and Interconnected Network of the Cytoskeleton

  2023cites this paper
• Molecular targets and mechanisms of anti-cancer effects of withanolides.

  2023cites this paper
• Phytochemical characterization and toxicological activity attributed to the acetonic extract of South American Vassobia breviflora

  2023cites this paper
• Withaferin A and Celastrol Overwhelm Proteostasis

  2023cites this paper
• Natural bioactive compounds and FOXO3a in cancer therapeutics: An update.

  2023cites this paper
• FOXO3a-regulated arginine metabolic plasticity adaptively promotes esophageal cancer proliferation and metastasis

  2023cites this paper
• The Potential Pharmacological Effects of Natural Product Withaferin A in Cancer: Opportunities and Challenges for Clinical Translation

  2023cites this paper
• Withaferin A Inhibits Fatty Acid Synthesis in Rat Mammary Tumors.

  2022cites this paper
• Withania somnifera: Progress towards a Pharmaceutical Agent for Immunomodulation and Cancer Therapeutics

  2022cites this paper
• Endophytic Fungi and Phytochemical Profile of Withania somnifera

  2022cites this paper
• FOXO3a in cancer drug resistance.

  2022cites this paper
• Adaptogenic activity of withaferin A on human cervical carcinoma cells using high-definition vibrational spectroscopic imaging.

  2022cites this paper
• Withania somnifera (L.) Dunal (Ashwagandha); current understanding and future prospect as a potential drug candidate

  2022cites this paper
• Plants with anticancer potency for breast cancer treatment

  2022cites this paper
• Withania somnifera (L.) Dunal: Phytochemistry, structure-activity relationship, and anticancer potential.

  2022cites this paper
• Study to Analyse the Chemotherapeutic Effect of Propolis And Withaferin-A on Benz (A) Pyrene Induced Lipid Peroxidation and Antioxidant System in Wistar Rats

  2022cites this paper
• Novel molecules as the emerging trends in cancer treatment: an update

  2022cites this paper
• Antitumor activity of withaferin-A and propolis in benz (a) pyrene-induced breast cancer

  2022cites this paper
• Withania somnifera Modulates Radiation-Induced Generation of Lung Cancer Stem Cells via Restraining the Hedgehog Signaling Factors

  2022cites this paper
• Effect of propolis on membrane bound enzymes linked with breast cancer

  2022cites this paper
• An Overview of Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Canine Tumors: How Far Have We Come?

  2022cites this paper
• Functional Validation of the Putative Oncogenic Activity of PLAU

  2022cites this paper
• Habb-e-Asgandh Suppresses Cell Proliferation and Induces Apoptosis through Mitochondria Dysfunction in Multiple Myeloma Cells (RPMI8226)

  2022cites this paper
• Molecular dynamics simulations and experimental studies reveal differential permeability of withaferin-A and withanone across the model cell membrane

  2021cites this paper
• The Role of Forkhead Box Q1 Transcription Factor in Anticancer Effects of Withaferin A in Breast Cancer

  2021cites this paper
• Phosphocatalytic Kinome Activity Profiling of Apoptotic and Ferroptotic Agents in Multiple Myeloma Cells

  2021cites this paper
• Withaferin A: From Ancient Remedy to Potential Drug Candidate

  2021cites this paper
• A Mannosylated, PEGylated Albumin as a Drug Delivery System for the Treatment of Cancer Stroma Cells

  2021cites this paper
• Plant Science Today

  2021cites this paper
• A Perspective on Withania somnifera Modulating Antitumor Immunity in Targeting Prostate Cancer

  2021cites this paper
• Vimentin Promotes the Aggressiveness of Triple Negative Breast Cancer Cells Surviving Chemotherapeutic Treatment

  2021cites this paper
• Biodiversity and Drug Discovery Approach to Natural Medicine

  2021cites this paper
• Ashwagandha: multiple health benefits

  2021cites this paper
• Perspectives on natural compounds in chemoprevention and treatment of cancer: an update with new promising compounds.

  2021cites this paper
• Role of integrative medicine in the continuum of care of breast cancer patients in the Indian context

  2021cites this paper
• Withaferin A—A Promising Phytochemical Compound with Multiple Results in Dermatological Diseases

  2021cites this paper
• Withaferin A exerts an anti-obesity effect by increasing energy expenditure through thermogenic gene expression in high-fat diet-fed obese mice.

  2020cites this paper
• Withania somnifera (L.) Dunal: A potential therapeutic adjuvant in cancer.

  2020cites this paper
• Gemcitabine Co-Encapsulated with Curcumin in Folate Decorated PLGA Nanoparticles; a Novel Approach to Treat Breast Adenocarcinoma

  2020cites this paper
• In silico elucidation of plausible inhibitory potential of Withaferin A of Withania somnifera medicinal herb against breast cancer targeting estrogen receptor.

  2020cites this paper
• Review on Anticancerous Therapeutic Potential of Withania somnifera (L.) Dunal.

  2020cites this paper
• High expression of FOXO3 is associated with poor prognosis in patients with hepatocellular carcinoma

  2020cites this paper
• Keeping abreast about Ashwagandha in breast cancer.

  2020cites this paper
• RNA-seq reveals novel mechanistic targets of withaferin A in prostate cancer cellss.

  2020cites this paper
• Screening and druggability analysis of some plant metabolites against SARS-CoV-2: An integrative computational approach

  2020cites this paper
• Mechanisms of Anti-Tumor Activity of Withania somnifera (Ashwagandha)

  2020cites this paper
• A brief review of secondary plant metabolites as anticancer agents

  2020cites this paper
• Anticancer Mechanism of Withania Somnifera and Its Bioactive Compounds : A Short Review Along with Computational Molecular Docking Study

  2020cites this paper
• A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer

  2020influential citation
• A systems pharmacology approach to determine the mechanisms of action of pleiotropic natural products in breast cancer from transcriptome data

  2020cites this paper
• Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19

  2020cites this paper
• Evaluation of Anti-tumour Effect of Withaferin A Using Molecular Markers in a Rat Model of Mammary Carcinogenesis

  2020cites this paper
• Withaferin A: from Ayurvedic folk medicine to preclinical anti-cancer drug.

  2020cites this paper
• RNA‐seq reveals novel cancer‐selective and disease subtype‐independent mechanistic targets of withaferin A in human breast cancer cells

  2020cites this paper
• Overview of the anticancer activity of withaferin A, an active constituent of the Indian ginseng Withania somnifera

  2020cites this paper
• Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects

  2020influential citation
• Withaferin A suppresses breast cancer cell proliferation by inhibition of the two-pore domain potassium (K2P9) channel TASK-3.

  2020cites this paper
• Vimentin Intermediate Filaments as Potential Target for Cancer Treatment

  2020cites this paper
• Inhibition of cancer cell growth in cisplatin-resistant human oral cancer cells by withaferin-A is mediated via both apoptosis and autophagic cell death, endogenous ROS production, G2/M phase cell cycle arrest and by targeting MAPK/RAS/RAF signalling pathway.

  2020cites this paper
• RNA-seq reveals novel mechanistic targets of withaferin A in prostate cancer cells

  2020cites this paper
• Synergistic combinations of paclitaxel and withaferin A against human non-small cell lung cancer cells

  2020cites this paper
• Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives

  2020cites this paper
• Impeding the single-strand annealing pathway of DNA double-strand break repair by withaferin A-mediated FANCA degradation.

  2019cites this paper
• Prenatal epigenetics diets play protective roles against environmental pollution

  2019cites this paper
• Herbo-mineral formulation ‘Ashwashila’ attenuates rheumatoid arthritis symptoms in collagen-antibody-induced arthritis (CAIA) mice model

  2019cites this paper
• Withaferin A ameliorates renal injury due to its potent effect on inflammatory signaling.

  2019cites this paper
• Bioactive Compounds: Multi-Targeting Silver Bullets for Preventing and Treating Breast Cancer

  2019influential citation
• Withaferin A inhibits lysosomal activity to block autophagic flux and induces apoptosis via energetic impairment in breast cancer cells.

  2019cites this paper
• Intermediate Filaments as Potential Target for Cancer 2 Treatment

  2019cites this paper
• Withaferin A Prevents Myocardial Ischemia/Reperfusion Injury by Upregulating AMP-Activated Protein Kinase-Dependent B-Cell Lymphoma2 Signaling.

  2019cites this paper
• Withaferin-A Inhibits Growth of Drug-Resistant Breast Carcinoma by Inducing Apoptosis and Autophagy, Endogenous Reactive Oxygen Species (ROS) Production, and Inhibition of Cell Migration and Nuclear Factor kappa B (Nf-κB)/Mammalian Target of Rapamycin (m-TOR) Signalling Pathway

  2019cites this paper